Dosing of cancer patients with low or absent renal function.
Boddy
Alan
A
Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne and Derby Hospitals NHS Trust, Derby, UK. alan.boddy@ncl.ac.uk
Griffin
Melanie
M
Knowles
Sarah
S
Persic
Mojca
M
Scott
Ian
I
Errington
Julie
J
Veal
Gareth
G
D019540:Area Under Curve; D016190:Carboplatin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D005047:Etoposide / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy*; D051437:Renal Insufficiency / Q000150:complications*
D005047:Etoposide; D016190:Carboplatin